Description
A brain-penetrant, selective inhibitor of ABHD6 (IC50 = 0.43 µM) that has been used to decrease seizure incidence in a genetic mouse model of juvenile Huntington’s disease as well as in chemically-induced epilepsy models
Formal name: N-([1,1′-biphenyl]-3-ylmethyl)-N-methyl-carbamic acid, 4′-(aminocarbonyl)[1,1′-biphenyl]-4-yl ester
Synonyms:
Molecular weight: 436.5
CAS: 1338574-83-6
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids||Research Area|Neuroscience|Neurodegenerative Disorders|Huntington’s Disease||Research Area|Neuroscience|Seizure Disorders